Management revised FY 2025 revenue guidance from $900M-$950M to $850M-$900M due to project timing delays. Despite this, they anticipate a return to profitability in the second half of FY 2025, ...
Oracle Life Sciences has been named a 'Leader' in the Everest Group Life Sciences Clinical Trial Management System (CTMS) Products PEAK Matrix® Assessment 2024. This designation underscores Oracle's ...
This is the worst leave management company ever ... first lady faxed AND emailed me a copy of the requested documents. Matrix process is completely inefficient and inconsistent.
Feb. 3, 2025 /PRNewswire/ -- SCOPE 2025 – Oracle Life Sciences has been named a 'Leader' in the Everest Group Life Sciences Clinical Trial Management System (CTMS) Products PEAK Matrix ...
Matrix, an OEM in Security and Telecom solutions, is excited to announce its participation in the 27th CMDA IT Expo 2025, scheduled for February 10-11 at The Westin, Koregaon Park, Pune.As a ...
ORLANDO, Fla. , Feb. 3, 2025 /PRNewswire/ -- SCOPE 2025 – Oracle Life Sciences has been named a ‘Leader’ in the Everest Group Life Sciences Clinical Trial Management System (CTMS) Products PEAK ...